Eligibility of outpatients with chronic heart failure for sodium–glucose co‐transporter‐2 inhibitors

AIMS: Sodium–glucose co‐transporter‐2 inhibitors (SGLT2i) have been shown to have a relevant role in the prevention of hospitalizations for heart failure and improvement in the life expectancy of patients with diabetes and outpatients with chronic heart failure (CHF) with reduced left ventricular ej...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelini, Gianmarco, Albanese, Miriam, Ursi, Raffaella, Lisi, Francesco, Bellino, Maria Consiglia, Amato, Luca, Gioia, Margherita Ilaria, Parisi, Giuseppe, Brunetti, Natale Daniele, Piazzolla, Giuseppina, Ciccone, Marco Matteo, Iacoviello, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318395/
https://www.ncbi.nlm.nih.gov/pubmed/33991178
http://dx.doi.org/10.1002/ehf2.13380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318395/
https://www.ncbi.nlm.nih.gov/pubmed/33991178
http://dx.doi.org/10.1002/ehf2.13380

Ejemplares similares